Is a complete JSPR research report available?

No complete published report is available for Jasper Therapeutics, Inc. (JSPR) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Jasper Therapeutics, Inc. (JSPR)

NASDAQ: JSPR · USD

$0.62

+0.02 (+3.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first JSPR analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	17.4M
Net income (ttm)	-55.7M
EPS (ttm)	-$2.47
Shares out	28M
Volume	499,136
Beta	3.07
Price target	$9.17	+1377.1%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -55.7M
EPS (ttm): -$2.47
Market cap: 17.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All JSPR indicators

Market & fundamental data

Available fields

186

Groups with data

Currency

USD

Showing 186 of 186 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001788028
Company name	Jasper Therapeutics, Inc.
Country	United States
Country code	US
Cusip	471871202
Employees	22
Employees Change	-42%
Employees Change Percent	-65.63
Enterprise value	$3.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US4718712023
Last refreshed	2026-07-31
Market cap	$17.4M
Market cap category	Nano-Cap
Price	$0.62
Price currency	USD
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	2836
Symbol	JSPR
Website	https://jaspertx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-323.01%
FCF yield	-399.17%
P/B ratio	4.94x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-55.7M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Profit Per Employee	$-2.5M
ROA	-112.2
Roa5y	-57.44
ROCE	-599.2
ROE	-244.2
Roe5y	-118.9
ROIC	-180.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-78.98%
Cagr3y	-65.7%
Cagr5y	-63.75%
EPS Growth Quarters	3
EPS Growth Years	5
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$21.2M
Cash	$14.1M
Current Assets	$20.3M
Current Liabilities	$9M
Debt	$757,000
Debt Equity	$0.22
Equity	$3.4M
Liabilities	$17.8M
Long Term Assets	$892,000
Long Term Liabilities	$8.8M
Net Cash	$13.4M
Net Cash By Market Cap	$77.59
Net Cash Growth	-71.03%
Net Debt Equity	$-3.94
Tangible Book Value	$3.4M
Tangible Book Value Per Share	$0.12
WACC	20.27

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.26
Net Working Capital	$-2.1M
Quick ratio	1.57
Working Capital	$11.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-50.47%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-78.96%
200-day SMA	1.27
3Y total return	-95.97%
50-day SMA	0.61
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.37%
All Time High	188.8
All Time High Change	-99.67%
All Time High Date	2021-10-15
All Time Low	0.32
All Time Low Change	97.02%
All Time Low Date	2026-06-29
ATR	0.1
Beta	3.07
Beta1y	2.44
Beta2y	2.82
Ch YTD	-66.08
High	0.64
High52	3.14
High52 Date	2025-08-15
High52ch	-80.23%
Low	0.58
Low52	0.32
Low52 Date	2026-06-29
Low52ch	97.02%
Ma50ch	2.24%
Premarket Change Percent	-2.41
Premarket Price	$0.59
Premarket Volume	562
Price vs 200-day SMA	-51.04%
RSI	47.96
RSI Monthly	31.3
RSI Weekly	37.64
Sharpe ratio	-1.1x
Sortino ratio	-1.41
Total Return	-50.47%
Tr YTD	-66.08
Tr1m	47.88%
Tr1w	-14.85%
Tr3m	-30.27%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	2
Analyst Price Target Top	$3
Analyst Ratings	Buy
Analyst Ratings Top	Hold
Earnings EPS Estimate	$-0.52
Operating Income	$-70.7M
Price target	$9.17
Price Target Change	$1,377
Price Target Change Top	$383

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	23,307,469%
Float Percent	83.25%
Shares Insiders	3.05%
Shares Institutions	43.2%
Shares Out	27,996,819
Shares Qo Q	0.03%
Shares Yo Y	50.47%
Short Float	7.13%
Short Ratio	2.23
Short Shares	5.94

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-74.2M
Adjusted OCF	-74,192,000
Average Volume	3,192,637.5x
Bv Per Share	0.12
CAPEX	$-7,000
Ch1m	47.88
Ch1w	-14.85
Ch1y	-78.96
Ch3m	-30.27
Ch3y	-95.97
Ch5y	-99.37
Ch6m	-59.95
Change	3.45%
Change From Open	3.47
Close	0.6
Days Gap	-0.02
Depreciation Amortization	798,000
Dollar Volume	309,863.6
Earnings Date	2026-08-11
Earnings Time	amc
EBIT	$-73M
EBITDA	$-72.2M
EPS	$-2.47
F Score	0
FCF	$-68.9M
FCF EV Yield	-1,780.87x
FCF Per Share	$-2.46
Financing CF	34,211,000
Fiscal Year End	December
Founded	2,018
Investing CF	1,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Last Split Date	2024-01-04
Last Split Type	Reverse
Last10k Filing Date	2026-03-30
Ma150	1.04
Ma150ch	-40.08%
Ma20	0.65
Ma20ch	-4.7%
Net CF	-34,655,000
Next Earnings Date	2026-08-12
Open	0.6
Optionable	Yes
Position In Range	66.94
Post Close	0.62
Postmarket Change Percent	-0.13
Postmarket Price	$0.62
Ppne	398,000
Pre Close	0.6
Price Date	2026-07-30
Ptbv Ratio	5.07
Relative Volume	0.16x
Share Based Comp	5,325,000
Tr6m	-59.95%
Us State	California
Volume	499,136

Jasper Therapeutics, Inc. (JSPR)

Coverage state: Market snapshot only — no published research

Generate the first JSPR analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · JSPR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All JSPR indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on JSPR

Frequently asked questions